Pharma Mar Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	17.82	63.24	60.02	149.81	113.35
Short-Term Investments	149.41	91.29	102.54	32.61	88.53
Cash & Short-Term Investments	167.22	154.53	162.56	182.42	201.88
Cash Growth	8.22%	-4.94%	-10.89%	-9.64%	3.26%
Accounts Receivable	39.05	34.27	27.2	29.32	50.91
Other Receivables	0.36	0.41	0.35	-	-
Receivables	39.41	34.68	27.55	29.32	50.91
Inventory	50.64	50.89	39.29	27.75	10.54
Prepaid Expenses	1.5	1.74	2.92	5.98	3.91
Other Current Assets	24.65	8.41	20.28	29.71	28
Total Current Assets	283.42	250.25	252.6	275.18	295.23
Property, Plant & Equipment	60.12	57.75	34.54	33.23	26.9
Long-Term Investments	0.58	2.46	6.06	49.4	10.72
Other Intangible Assets	1.36	1	1.23	1.19	1.13
Long-Term Deferred Tax Assets	46.55	36.01	31.47	30.53	27.75
Long-Term Deferred Charges	2.19	-	0.7	1.4	2.11
Other Long-Term Assets	0.87	2.18	13.91	2.33	4.55
Total Assets	395.08	349.64	340.52	393.26	368.39
Accounts Payable	40.91	38.81	29.17	27.49	26.93
Accrued Expenses	14.31	13.57	12.39	10.44	9.5
Short-Term Debt	4.79	4.72	6.46	4.48	3.84
Current Portion of Long-Term Debt	6.24	3.25	6.37	8.64	8.37
Current Portion of Leases	1.71	1.88	1.98	1.61	1.82
Current Unearned Revenue	7.74	5.38	25.93	26.11	30.89
Other Current Liabilities	18.18	15.08	13.59	18.54	4.99
Total Current Liabilities	93.88	82.69	95.89	97.32	86.35
Long-Term Debt	35.55	39.87	27.04	25.88	33.39
Long-Term Leases	1.13	1.36	1.83	2.01	1.92
Long-Term Unearned Revenue	12.64	17.17	22.14	44.9	68.63
Other Long-Term Liabilities	0.05	0.19	0.19	0.19	0.19
Total Liabilities	143.25	141.29	147.08	170.3	190.47
Common Stock	10.8	10.93	11.01	11.01	11.01
Additional Paid-In Capital	45.91	59.86	71.28	71.28	71.28
Retained Earnings	233.83	168.38	142.22	156.51	121.29
Treasury Stock	-38.72	-30.83	-31.09	-15.87	-25.68
Comprehensive Income & Other	0.02	0.02	0.02	0.02	0.02
Total Common Equity	251.83	208.36	193.44	222.96	177.92
Shareholders' Equity	251.83	208.36	193.44	222.96	177.92
Total Liabilities & Equity	395.08	349.64	340.52	393.26	368.39
Total Debt	49.42	51.08	43.67	42.63	49.33
Net Cash (Debt)	117.81	103.45	118.89	139.79	152.55
Net Cash Growth	13.88%	-12.99%	-14.95%	-8.36%	9.86%
Net Cash Per Share	6.75	5.89	6.64	7.74	8.44
Filing Date Shares Outstanding	17.36	17.57	17.64	18.11	18.01
Total Common Shares Outstanding	17.36	17.57	17.64	18.11	18.01
Working Capital	189.54	167.55	156.71	177.86	208.89
Book Value Per Share	14.51	11.86	10.97	12.31	9.88
Tangible Book Value	250.48	207.36	192.2	221.77	176.79
Tangible Book Value Per Share	14.43	11.80	10.90	12.25	9.82
Land	37.86	36.04	29.04	29.04	22.59
Machinery	64.18	60.68	43.28	27.87	24.32

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.